Edition:
India

Profile: Nicox SA (NCOX.PA)

NCOX.PA on Paris Stock Exchange

4.43EUR
15 Nov 2019
Change (% chg)

€-0.06 (-1.45%)
Prev Close
€4.49
Open
€4.46
Day's High
€4.48
Day's Low
€4.42
Volume
58,385
Avg. Vol
55,533
52-wk High
€7.14
52-wk Low
€4.30

Nicox SA is a France-based international ophthalmic company. It is engaged in the field of the research, development and future commercialization of investigational drugs for ophthalmological diseases. The Company’s aim is to build a portfolio of therapeutic products addressing the needs of eye care practitioners and patients. Nicox SA offers its customers the Xailin range of ocular lubricants and AdenoPlus, a diagnostic test that aids in the differential diagnosis of acute conjunctivitis. The Company has also products in the pipeline, such as VESNEO (a drug-candidate for treating glaucoma) and AC-170 (for allergic conjunctivis). It has a direct commercial presence in Germany, France, the United Kingdom, Italy and Spain, as well as partnerships with local distributors in a number of key international markets.

Company Address

Nicox SA

Drakkar 2 - Batiment D
2405 route des Dolines
CS 10313 Sophia Antipolis
VALBONNE     06560
P: +334.97245300
F: +334.97245399

Company Web Links